PLOS ONE: The diagnostic predictive value of neutrophil-to-lymphocyte ratio in thyroid cancer adjusted for tumor size
![Thyroid cancers of follicular origin in a genomic light: in-depth overview of common and unique molecular marker candidates | Molecular Cancer | Full Text Thyroid cancers of follicular origin in a genomic light: in-depth overview of common and unique molecular marker candidates | Molecular Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12943-018-0866-1/MediaObjects/12943_2018_866_Fig2_HTML.png)
Thyroid cancers of follicular origin in a genomic light: in-depth overview of common and unique molecular marker candidates | Molecular Cancer | Full Text
![Introduction and expression of PIK3CAE545K in a papillary thyroid cancer BRAFV600E cell line leads to a dedifferentiated aggressive phenotype | Journal of Otolaryngology - Head & Neck Surgery | Full Text Introduction and expression of PIK3CAE545K in a papillary thyroid cancer BRAFV600E cell line leads to a dedifferentiated aggressive phenotype | Journal of Otolaryngology - Head & Neck Surgery | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40463-022-00558-w/MediaObjects/40463_2022_558_Figa_HTML.png)
Introduction and expression of PIK3CAE545K in a papillary thyroid cancer BRAFV600E cell line leads to a dedifferentiated aggressive phenotype | Journal of Otolaryngology - Head & Neck Surgery | Full Text
![Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2ac605a6-1688-4b84-8521-c9877c4bb06e/gr1_lrg.jpg)
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
![Thyroid tumor-initiating cells: Increasing evidence and opportunities for anticancer therapy (Review) Thyroid tumor-initiating cells: Increasing evidence and opportunities for anticancer therapy (Review)](https://www.spandidos-publications.com/article_images/or/31/3/OR-31-03-1035-g01.jpg)
Thyroid tumor-initiating cells: Increasing evidence and opportunities for anticancer therapy (Review)
![Molecular Pathology of Poorly Differentiated and Anaplastic Thyroid Cancer: What Do Pathologists Need to Know? | SpringerLink Molecular Pathology of Poorly Differentiated and Anaplastic Thyroid Cancer: What Do Pathologists Need to Know? | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12022-021-09665-2/MediaObjects/12022_2021_9665_Fig1_HTML.png)
Molecular Pathology of Poorly Differentiated and Anaplastic Thyroid Cancer: What Do Pathologists Need to Know? | SpringerLink
![Role of tissue and circulating microRNAs and DNA as biomarkers in medullary thyroid cancer - ScienceDirect Role of tissue and circulating microRNAs and DNA as biomarkers in medullary thyroid cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0163725820302394-gr1.jpg)